Opendata, web and dolomites

Dyneelax SIGNED

The world’s first automated laximetry device that replicates daily movements and activities through a dynamic test.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Dyneelax project word cloud

Explore the words cloud of the Dyneelax project. It provides you a very rough idea of what is the project "Dyneelax" about.

clinical    device    human    core    ligament    sme    roadmap    resonance    body    diagnosing    invasive    emergency    post    anterior    practitioners    status    injury    market    fragile    laxity    components    diagnosis    ray    knee    looseness    ideal    magnetic    prioritise    unpredictable    acl    mri    vital    laximetry    healthcare    ligaments    scan    instrument    orthopaedist    point    protocol    mission    imaging    examinations    confirm    mechanised    sometimes    motion    first    entirely    patients    joint    contrast    quicker    replacing    reproducible    limited    gold    tests    treatment    healthy    lachman    contact    waiting    overcome    injuries    diagnose    prognosis    stabilising    specialists    dynamic    completing    claim    genourob    periods    wait    automation    exams    recovery    surveillance    dyneelax    independent    gps    medical    standard    cruciate    quantitative    specialist    automated    substitute    function    scans    standardisation    transform    rotational    grant    joints    carries   

Project "Dyneelax" data sheet

The following table provides information about the project.

Coordinator
GENOUROB 

Organization address
address: BAT 60 RUE HENRI GERET
city: LAVAL
postcode: 53000
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-07-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GENOUROB FR (LAVAL) coordinator 50˙000.00

Map

 Project objective

The knee is the largest, and one of the most complex and fragile joints in the human body, and the anterior cruciate ligament (ACL) is one of its core components. The ACL is vital to healthy knee function, stabilising the joint throughout its range of motion. In order to diagnose ACL injuries, the current gold standard is the Lachman’s test, which measures the ‘laxity’ (looseness) of the ligaments in the knee. Often done by hand, this is a reliable process when carried out by a specialist such as an orthopaedist. In contrast, general practitioners (GPs) and other non-specialists require x-ray or magnetic resonance imaging (MRI) exams to confirm their diagnosis. However, waiting periods for mechanised tests in the EU are long, sometimes entirely unpredictable, due to limited equipment availability and the need to prioritise emergency cases.

To overcome this, Genourob has developed Dyneelax, which is the first medical device for automated dynamic laximetry measurement. Dyneelax carries out objective and reproducible Lachman’s tests and rotational exams to assess the laximetry of the ACL. Automation and standardisation of this non-invasive, quantitative testing allows the diagnosis and prognosis of ACL injury and recovery status. It is independent of examinations such as x-ray and MRI scans and it can be used also by non-specialists such as GPs. This means quicker, more effective treatment for better recovery of patients.

At Genourob our mission is to transform the clinical protocol for diagnosing and prognosis of ACL injuries. In this way, GPs would be patients’ main point of contact with the healthcare system, replacing the need to wait for an MRI scan or x-ray for ACL injuries’ treatment. The SME Instrument grant is ideal for completing our product roadmap as it will enable our post-market surveillance to be carried out, to allow us to make the clinical claim that Dyneelax is an effective substitute for MRI scans in diagnosing and evaluating injuries to the ACL

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "DYNEELAX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "DYNEELAX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

SCAT (2019)

Smart Composites for Additive Technology

Read More  

Cortx (2019)

Intelligent debt recovery platform.

Read More  

Yodiwo FEMP (2019)

An eco-friendly, Integrated Facility and Energy Management Platform for continuous reduction of infrastructure operating cost, driven by AI.

Read More